Home / News / Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO

Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO

Read the full article: Global News Wire

12 January 2026

Posted in — News

Share
Share

You may also like

17 April 2026

Meet the women steering Australia’s high-tech future

News, The Australian Financial Review

17 April 2026

Eucalyptus sells to New York-listed healthcare giant in $1.6b deal

News, The Australian Financial Review

15 October 2025

Accel-KKR Acquires Phocas Software

News, The Australian Financial Review

04 September 2025

Australian Investment Council announces 2025 investing for growth award winners

News

View All

Ventured. Gained.
decor